{"cveId": "CVE-2022-43557", "cwe": ["CWE-1299", "CWE-1299", "CWE-287", "CWE-1299", "CWE-287"], "cvss": [{"baseScore": "5.3", "version": "3.1", "Attack Vector": "Physical", "Attack Complexity": "High", "Privileges Required": "None", "User Interaction": "None", "Scope": "Unchaged", "Confidentiality Impact": "Low", "Integrity Impact": "Low", "Availability Impact": "High"}], "references": ["https://www.bd.com/en-us/about-bd/cybersecurity/bulletin/bd-bodyguard-pumps-rs-232-interface-vulnerability"], "description": ["The BD BodyGuard™ infusion pumps specified allow for access through the RS-232 (serial) port interface. If exploited, threat actors with physical access, specialized equipment and knowledge may be able to configure or disable the pump. No electronic protected health information (ePHI), protected health information (PHI) or personally identifiable information (PII) is stored in the pump."], "published": "2022-12-05T22:15:11.157", "state": "PUBLIC", "vendorName": ["Becton, Dickinson and Company (BD)"], "productName": ["BodyGuard™ Pump"], "github": {"advisories": [], "commits": [], "pocAdvisorie": null, "repo": null, "info": {}}, "pocList": []}